logo header
                                                Login

ABOUT DoReMi

 

hmscholar

DoReMi Network of excellence

The DoReMi addresses the health risks of low doses of ionising radiation such as those that are encountered in the environment, occupationally and in the course of medical diagnostic procedures. DoReMi was launched in January 2010 with 12 original partners, with a duration of six years. In July 2011, 10 new partners joined the consortium as a result of DoReMi's first competitive call. In January 2013, another 10 new partners joined the consortium as a result of DoReMi's second competitive call, making the total number of partners 32.


Project grant agreement number: 249689
Project full name: Low Dose Research towards Multidisciplinary Integration
Budget : 13 M€ (EC contribution)

Highlights
  • Aim & Objectives

The purpose of DoReMi is to promote the sustainable integration of low dose risk research in Europe in order to aid the effective resolution of the key policy questions identified by the High Level Expert Group (HLEG) on Low Dose Risk Research (www.hleg.de).

DoReMi provides an operational tool for the development of the proposed MELODI platform (Multidisciplinary European Low Dose Risk Re-search Initiative - www.melodi-online.eu ) consisting of major national bodies and research programmes that have long term commitment in low dose risk research in Europe.

Highlights
  • Organisation : WPs chart
    (Please click the link below to access each WP)

Highlights
  • WP1 Network coordination and Management

The purpose of this WP is to ensure the effective administrative and financial management of the project in order to reach a good synergy between the partners. The overall objective of the managerial organisation is to provide necessary structures for participatory and efficient decision-making and coordination of RTD and other activities, fluent day-to-day management including flow of information and financing, reporting to EC, as well as providing support and guidance on project activities. STUK is responsible for the network coordination and management. The tasks related to this are:

•  Overall legal, contractual and administrative management
•  Overall financial management
•  Establishment and implementation of the quality assurance (QA) activities
•  Periodic meetings and activities of the General Assembly (GA), Management Board (MB) and External Advisory Board     (EAB)
•  Follow-up for Performance indicators
•  Management of flexibility funding
•  Contingency planning


Highlights
  • NoE Members
Participant no.
Participant organisation name
Country Website
1. (Coordinator) Radiation and Nuclear Safety Authority (STUK) Finland http://www.stuk.fi
2. Institut de Radioprotection et de Sûreté Nucléaire (IRSN) France http://www.irsn.org
3. Helmholz Zentrum München (HMGU) Germany
4. Commissariat à l'Energie Atomique et aux Energies Alternatives (CEA) France http://www.cea.fr
5. Health Protection Agency (HPA) UK http://www.hpa.org.uk
6. University of Pavia (UNIPV) Italy http://www.unipv.it
7. Istituto Superiore di Sanitá (ISS) Italy http://www.iss.it
8. Belgian Nuclear Research Centre (SCK-CEN) Belgium http://www.sckcen.be
9. Bundesamt für Strahlenschutz (BfS) Germany http://www.bfs.de
10. University of Stockholm (SU) Sweden http://www.su.se
11. Centre for Research in Environmental Epidemiology (CREAL) Spain http://www.creal.cat
12. Institut Curie (IC) France http://www.curie.fr
13. Universitaetsklinikum Erlangen (UKER) Germany http://www.english.uk-erlangen.de
14. Johann Wolfgang Goethe Universitaet, Frankfurt am Main (GUF) Germany http://www.uni-frankfurt.de
15. Universitaet Rostock (UROS) Germany http://www.uni-rostock.de
16. Norwegian University of Life Sciences (UMB) Norway http://www.umb.no
17. Norwegian Radiation Protection Authority (NRPA) Norway http://www.nrpa.no
18. Nasjonalt Folkehelseinstitutt (NIPH) Norway http://www.fhi.no
19. Agenzia Nazionale per le Nuove Tecnologie, l’Energia e lo Sviluppo Economico Sostenibile (ENEA) Italy http://old.enea.it
20. Institute for Environmental Sciences (IES) Japan http://www.ies.or.jp
21. Dublin Institute of Technology (DIT) Ireland http://www.dit.ie
22. Erasmus Universitair Medisch Centrum Rotterdam (ERASMUS) Netherland http://www.erasmusmc.nl
23. Oxford Brookes University (OBU) UK http://www.brookes.ac.uk
24. Brunel University (UBUN) UK http://www.brunel.ac.uk
25. "Frédéric Joliot Curie" National Research Institute for Radiobiology and Radiohygiene (NRIRR) Hungary http://www.osski.hu
26. National Radiation Protection Institute
(SURO)
Czech-Republic http://www.suro.cz
27. NUVIA Limited (NUVIA) UK http://www.nuvia.co.uk
28. Atomic Weapons Establishment (AWE) UK http://www.awe.co.uk
29. Universitaet des Saarlandes (USAAR) Germany http://www.uni-saarland.de
30. Leiden University Medical Center (LUMC) Netherlands https://www.lumc.nl
31. Universität der Bundeswehr München
(UBWM)
Germany http://www.unibw.de
32. Ludwig‐Maximilians‐ Universität München (LMU) Germany http://www.en.uni-muenchen.de
33. Sofia University “St. Kliment Ohridski” (SUN) Bulgaria https://www.uni-sofia.bg
34. Nofer Institute of Occupational Medicine (NIOM) Poland http://www.imp.lodz.pl
35. Military Institute of Hygiene and
Epidemiology (MIHE)
Poland http://www.wihe.waw.pl
36. Jagiellonian University (UJ) Poland http://www.uj.edu.pl
*37. Department of Health (DH-PHE) UK https://www.gov.uk
* Partial transfer of rights and obligations from beneficiary 5 HPA to Department of Health, Public Health England, PHE

 

  • Joint Programme of Activities
Three main activities covered by DoReMi:
•  A Joint Programme of Research (JPR) covering the issues outlined above and providing an overview of the needs for research infra-structures of pan-European interest and facilitating multilateral initiatives leading to better use and development of research infrastructures.
 A Joint Programme of Integration (JPI) to develop a coordinated European roadmap for the long term needs of the key players in Europe.
•  A Joint Programme for the Spreading of Excellence (JPSE), covering knowledge management, training and mobility and its implementation.
The JPR focuses on the areas identified by the HLEG as the most promising in terms of addressing/resolving the key policy questions, namely: the shape of dose response curve for cancer, individual susceptibilities and non-cancer effects. Radiation quality, tissue sensitivity and internal exposures will be addressed as cross cutting themes within the three main research areas. A substantial proportion of the JPA will be dedicated to the joint programme of research. The programme describes a multidisciplinary approach including interfaces with the broader biological toxicological and epidemiological communities. Strategic planning will be carried out in close collaboration with MELODI (www.melodi-online.eu/)